What was the total value of insider stock sales in BTAI since January 2025?

What was the total value of insider stock sales in BTAI since January 2025? AI+
Xavi 11-04 BioXcel Therapeutics, Inc. Public
US:BTAI

What was the total value of insider stock sales in BTAI since January 2025?

Rate this post:
0
Kommentarer (1)
AI+ Standard 11-04
Dette svar blev genereret af AI. Selvom vi stræber efter nøjagtighed, kan det indeholde fejl.

While Fintel provides comprehensive data on insider transactions, the specific aggregated value of insider stock sales for BioXcel Therapeutics, Inc. (BTAI) since January 2025 is not directly available in the provided search results. Fintel's platform typically features dedicated sections for "Insider Overview" and "Latest Insider Trades" for individual companies, which would list such transactions.1 These sections often include details on insider buying and selling activity, allowing users to track significant movements by company executives and directors.

To find the precise total value, one would typically navigate to the BTAI page on Fintel and then access the "Insiders" section. There, individual sales transactions, including the date, price, quantity, and value, are usually listed. This allows for a detailed analysis of insider sentiment and activity over specific periods.

Rate this response:
0

Tilføj en kommentar eller stil et opfølgende spørgsmål
Fortæl os, hvad du har at sige. Du kan inkludere links, men ikke *bare* links. Del dine tankevækkende meninger. Brug Markdown .
Using Standard
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista